Israeli baby formula maker Else to complete share offering this week

TEL AVIV (Reuters) – Israel’s Else Nutrition BABY.V, which has developed a plant-based infant formula not made from soy, plans to complete a C$25.7 million ($19.3 million) private placement of its shares this week, its chief executive said.

Shareholder H&H International Holding 1112.HK of Hong Kong has bought 11.6% of the shares offered, while Canaccord Genuity CF.TO has taken the rest to sell to investors, Else CEO Hamutal Yitzhak told Reuters.

Else’s formula, made from almonds, buckwheat and tapioca, is organic, vegan and gluten free. Many babies allergic to cow’s milk are also allergic to soy-based formula, Yitzhak said.

“Currently cow’s milk accounts for more than 90% of the market and soy protein for less than 10%,” she said.

Almond is 10 times less allergenic than cow’s milk among babies, according to a 201‮8‬ U.S. allergy prevalence study, said Yitzhak, former head of infant nutrition at Abbott Labs Israel.

Read More

Study: cow’s milk formula doubles babies’ risk for asthma compared with breastfeeding

Oct. 2 (UPI) — Infants who receive cow’s milk-based formula in addition to breast milk are nearly twice as likely to develop asthma or recurrent wheeze, according to a study published Friday by JAMA Network Open.

Among infants who received milk formula as a supplement to breastfeeding from birth to 5 months, 18% developed asthma or recurrent wheezing, the data showed.

Conversely, only 10% of the infants who were breastfed only — as well as those who received breast milk plus amino acid-based elemental formula — during their first few months of life experienced these breathing issues, the researchers said.

“Breastfeeding with or without elemental formula for the first three days or more of life appeared to decrease the risk of asthma or recurrent wheeze in young children compared with breastfeeding plus a small amount of cow’s milk formula from the first day of life,” wrote the researchers from Jikei

Read More